Non-Hodgkin’s lymphoma incidence and survival in European children and adolescents (1978–1997): Report from the Automated Childhood Cancer Information System project

Cancer incidence and mortality in children in the Mexican Social Security Institute (1996-2013)

“…13 In European children, there was an increasing trend in general, but this only occurred in the southern and western regions of Europe. 19 Data from our study showed a decreasing trend, and in a more detailed study of lymphomas that was performed by our group, the mixed cellularity subtype decreased in Hodgkin's lymphomas; non-Hodgkin's lymphomas also displayed a decreasing trend, particularly in the unspecified types, which was identified as an improvement in the histopathological diagnosis in recent years. 20 In relation to mortality exclusively, which, as mentioned, is related to the overall efficacy of treatment that is being administered to the population, 6,21 only the data from the period of 2003-2013 should be considered because during this period, the incidence was stable and it could be verified that the incidence differed from what occurred in developed countries, where the cancer mortality in children decreased.…”

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

“…39 Furthermore, the characteristics shared by the lymphomas of all the patients argue strongly against random occurrence. This increased risk of lymphomas might conceivably have been related to the immunosuppressive therapy that 4 of the 5 patients were receiving as treatment for IBD.…”

Lymphomák adoleszcens korban: Érdemes-e gyermek-protokollal kezelni ezt a betegcsoportot?

“…Míg gyermekkorban a leukaemiák (27%), központi idegrendszeri tumorok (KIR) (25%) és lymphomák (12%) a leggyakoribb onkológiai kórképek, addig az AFF-ban első helyen a lymphomák állnak (HL: 16%, NHL: 10%), megelőzve a leukaemiákat és a KIR tumorokat (12% és 10%) (3). Az ACCIS (Automated Childhood Cancer Information System) adatbázis 1978 és 1997 közö i adatai azt mutatják, hogy az adoleszcens kori non-Hodgkin-lymphoma incidenciája évente 1,7%-kal növekszik (14).…”